These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33103259)

  • 1. Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition.
    Rubio-Ruiz B; Serrán-Aguilera L; Hurtado-Guerrero R; Conejo-García A
    Med Res Rev; 2021 Mar; 41(2):902-927. PubMed ID: 33103259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
    Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
    PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
    Arlauckas SP; Popov AV; Delikatny EJ
    Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.
    Hong BS; Allali-Hassani A; Tempel W; Finerty PJ; Mackenzie F; Dimov S; Vedadi M; Park HW
    J Biol Chem; 2010 May; 285(21):16330-40. PubMed ID: 20299452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
    Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
    Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline kinase alpha depletion selectively kills tumoral cells.
    Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
    Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.
    Ramírez de Molina A; Rodríguez-González A; Penalva V; Lucas L; Lacal JC
    Biochem Biophys Res Commun; 2001 Jul; 285(4):873-9. PubMed ID: 11467831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Unique Inhibitor-Binding Site on Choline Kinase α.
    Kall SL; Delikatny EJ; Lavie A
    Biochemistry; 2018 Feb; 57(8):1316-1325. PubMed ID: 29389115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.
    Lacal JC; Zimmerman T; Campos JM
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline kinase: an important target for cancer.
    Janardhan S; Srivani P; Sastry GN
    Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
    Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
    Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
    Zimmerman T; Moneriz C; Diez A; Bautista JM; Gómez Del Pulgar T; Cebrián A; Lacal JC
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5878-88. PubMed ID: 24041883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline kinase inhibition in rheumatoid arthritis.
    Guma M; Sanchez-Lopez E; Lodi A; Garcia-Carbonell R; Tiziani S; Karin M; Lacal JC; Firestein GS
    Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.
    Gallego-Ortega D; Gómez del Pulgar T; Valdés-Mora F; Cebrián A; Lacal JC
    Adv Enzyme Regul; 2011; 51(1):183-94. PubMed ID: 21035492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B; Conejo-García A; Ríos-Marco P; Carrasco-Jiménez MP; Segovia J; Marco C; Gallo MA; Espinosa A; Entrena A
    Eur J Med Chem; 2012 Apr; 50():154-62. PubMed ID: 22348828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
    Hernández-Alcoceba R; Saniger L; Campos J; Núñez MC; Khaless F; Gallo MA; Espinosa A; Lacal JC
    Oncogene; 1997 Nov; 15(19):2289-301. PubMed ID: 9393874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
    Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
    Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
    Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline kinase: An underappreciated rheumatoid arthritis therapeutic target.
    Miriam Jose A; Rasool M
    Life Sci; 2022 Nov; 309():121031. PubMed ID: 36206833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.
    Su JS; Woods SM; Ronen SM
    NMR Biomed; 2012 Feb; 25(2):379-88. PubMed ID: 22253088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.